PDF4PRO ⚡AMP

Modern search engine that looking for books and documents around the web

Example: stock market

Nucleic Acid Pathogen Testing - Cigna

Medical Coverage Policy Effective Date .. 9/15/2021. Next Review 1/15/2022. Coverage Policy Number .. 0530. Nucleic acid Pathogen Testing Table of Contents Related Coverage Resources Overview .. 1 Preventive Care Services Coverage General Background ..3. Medicare Coverage Determinations ..8. Coding/Billing Information ..9. References ..36. INSTRUCTIONS FOR USE. The following Coverage Policy applies to health benefit plans administered by Cigna Companies. Certain Cigna Companies and/or lines of business only provide utilization review services to clients and do not make coverage determinations. References to standard benefit plan language and coverage determinations do not apply to those clients. Coverage Policies are intended to provide guidance in interpreting certain standard benefit plans administered by Cigna Companies.

(gonorrhea), genital herpes (herpes simplex virus [HSV] type 1 and 2), human papillomavirus (HPV), candida, syphilis and trichomoniasis (trichomonas vaginitis) may be appropriate for asymptomatic individuals with high-risk behavior (e.g., exposure to possible infected partner, high-risk conditions (e.g., pregnancy, HIV infection), or

Loading..

Tags:

  Pathogens, Testing, Human, Acid, Infections, Nucleic, Papillomavirus, Human papillomavirus, Nucleic acid pathogen testing

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Spam in document Broken preview Other abuse

Transcription of Nucleic Acid Pathogen Testing - Cigna

Related search queries